Mechanism
How Ipratropium works
Blocks muscarinic receptors in the airway, especially M3-mediated bronchoconstriction, reducing acetylcholine-driven bronchial smooth muscle contraction.
← Respiratory Pharmacology
SAMANBRC High Yield5/5 Importance
Ipratropium Respiratory Pharmacology Guide
Class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style study pearls.
Ipratropium is a short-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction. It is especially important in COPD and is often combined with albuterol during exacerbations. Expected side effects are anticholinergic, including dry mouth, throat irritation, blurred vision if sprayed into the eyes, and possible urinary retention. For NBRC-style questions, remember SAMA equals muscarinic blockade, not beta stimulation.
Clinical Pearl
What to remember
In acute COPD exacerbations, ipratropium is commonly paired with albuterol for additive bronchodilation.
Kinetics
Onset, peak, and duration
1
Onset
About 15 minutes
2
Peak
1 to 2 hours
3
Duration
4 to 6 hours
Quick facts
- Subclass
- SAMA
- NBRC importance
- 5/5
- Difficulty
- 1/5
- Brands
- Atrovent
Common indications
- COPD bronchospasm
- COPD exacerbation when combined with SABA
- Adjunct therapy in severe asthma exacerbation
Adverse effects
- Dry mouth
- Cough
- Throat irritation
- Blurred vision if aerosol contacts eyes
- Urinary retention
- Paradoxical bronchospasm
Contraindications
- Hypersensitivity to ipratropium, atropine derivatives, or formulation components
Cautions and safety issues
- Use caution with narrow-angle glaucoma
- Use caution with urinary retention or prostatic hyperplasia
- Avoid spraying into eyes
NBRC-style question
NBRC-style pharmacology review
A patient scenario involves copd exacerbation treated with saba plus sama. Which medication concept should the respiratory therapy student recognize?
High-yield answer
Ipratropium belongs to Short-Acting Muscarinic Antagonists.
Interactive practice
Practice in PharmaGenius
Master this medication through adaptive review of class, mechanism, indications, adverse effects, exam traps, and clinical scenarios. Missed concepts can later be surfaced for targeted remediation.
ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Common Exam Traps
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
- Short-acting beta agonist
- Long-acting muscarinic antagonist
- Inhaled corticosteroid
- Stimulates beta-2 receptors
- Primary rescue medication for exercise-induced bronchospasm
High-Yield Clinical Scenarios
- COPD exacerbation treated with SABA plus SAMA
- Severe asthma exacerbation as adjunct bronchodilator
- COPD maintenance symptom control
Related study paths
Continue building pharmacology mastery
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.